Depression: Esketamine trial leaves ‘more questions than answers’

A phase 3 clinical trial testing esketamine nasal spray in the treatment of severe depression found the spray mostly safe and effective. The findings led to the recent FDA approval of this treatment. Despite this, other researchers caution that “more question?
Read More